Logo image of ACLS

AXCELIS TECHNOLOGIES INC (ACLS) Stock Fundamental Analysis

NASDAQ:ACLS - Nasdaq - US0545402085 - Common Stock - Currency: USD

62.46  +0.45 (+0.73%)

After market: 62.46 0 (0%)

Fundamental Rating

7

ACLS gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the health and profitability get an excellent rating, making ACLS a very profitable company, without any liquidiy or solvency issues. ACLS may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, ACLS could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ACLS was profitable.
In the past year ACLS had a positive cash flow from operations.
ACLS had positive earnings in each of the past 5 years.
In the past 5 years ACLS always reported a positive cash flow from operatings.
ACLS Yearly Net Income VS EBIT VS OCF VS FCFACLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

1.2 Ratios

ACLS's Return On Assets of 13.28% is amongst the best of the industry. ACLS outperforms 84.55% of its industry peers.
With an excellent Return On Equity value of 17.33%, ACLS belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
ACLS has a better Return On Invested Capital (14.13%) than 87.27% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ACLS is significantly above the industry average of 11.17%.
The last Return On Invested Capital (14.13%) for ACLS is well below the 3 year average (21.34%), which needs to be investigated, but indicates that ACLS had better years and this may not be a problem.
Industry RankSector Rank
ROA 13.28%
ROE 17.33%
ROIC 14.13%
ROA(3y)17.39%
ROA(5y)14.66%
ROE(3y)25.25%
ROE(5y)20.89%
ROIC(3y)21.34%
ROIC(5y)18.4%
ACLS Yearly ROA, ROE, ROICACLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

ACLS's Profit Margin of 18.58% is fine compared to the rest of the industry. ACLS outperforms 80.00% of its industry peers.
ACLS's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 19.14%, ACLS is in the better half of the industry, outperforming 76.36% of the companies in the same industry.
In the last couple of years the Operating Margin of ACLS has grown nicely.
ACLS has a Gross Margin (44.61%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ACLS has remained more or less at the same level.
Industry RankSector Rank
OM 19.14%
PM (TTM) 18.58%
GM 44.61%
OM growth 3Y2.52%
OM growth 5Y24.03%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
ACLS Yearly Profit, Operating, Gross MarginsACLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

ACLS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
ACLS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ACLS has been reduced compared to 5 years ago.
Compared to 1 year ago, ACLS has an improved debt to assets ratio.
ACLS Yearly Shares OutstandingACLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACLS Yearly Total Debt VS Total AssetsACLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ACLS has an Altman-Z score of 6.34. This indicates that ACLS is financially healthy and has little risk of bankruptcy at the moment.
ACLS's Altman-Z score of 6.34 is fine compared to the rest of the industry. ACLS outperforms 66.36% of its industry peers.
ACLS has a debt to FCF ratio of 0.35. This is a very positive value and a sign of high solvency as it would only need 0.35 years to pay back of all of its debts.
ACLS's Debt to FCF ratio of 0.35 is amongst the best of the industry. ACLS outperforms 81.82% of its industry peers.
ACLS has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.04, ACLS is doing good in the industry, outperforming 60.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Altman-Z 6.34
ROIC/WACC1.22
WACC11.54%
ACLS Yearly LT Debt VS Equity VS FCFACLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 5.56 indicates that ACLS has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.56, ACLS belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
A Quick Ratio of 4.08 indicates that ACLS has no problem at all paying its short term obligations.
ACLS has a better Quick ratio (4.08) than 74.55% of its industry peers.
Industry RankSector Rank
Current Ratio 5.56
Quick Ratio 4.08
ACLS Yearly Current Assets VS Current LiabilitesACLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The earnings per share for ACLS have decreased strongly by -25.76% in the last year.
Measured over the past years, ACLS shows a very strong growth in Earnings Per Share. The EPS has been growing by 64.54% on average per year.
Looking at the last year, ACLS shows a very negative growth in Revenue. The Revenue has decreased by -15.14% in the last year.
ACLS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.30% yearly.
EPS 1Y (TTM)-25.76%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-33.76%
Revenue 1Y (TTM)-15.14%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-23.7%

3.2 Future

Based on estimates for the next years, ACLS will show a very strong growth in Earnings Per Share. The EPS will grow by 24.02% on average per year.
The Revenue is expected to decrease by -10.41% on average over the next years. This is quite bad
EPS Next Y-45.21%
EPS Next 2Y-23.26%
EPS Next 3Y24.02%
EPS Next 5YN/A
Revenue Next Year-25.43%
Revenue Next 2Y-10.41%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACLS Yearly Revenue VS EstimatesACLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
ACLS Yearly EPS VS EstimatesACLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.11 indicates a reasonable valuation of ACLS.
Compared to the rest of the industry, the Price/Earnings ratio of ACLS indicates a rather cheap valuation: ACLS is cheaper than 93.64% of the companies listed in the same industry.
ACLS is valuated cheaply when we compare the Price/Earnings ratio to 26.60, which is the current average of the S&P500 Index.
ACLS is valuated rather expensively with a Price/Forward Earnings ratio of 17.25.
Based on the Price/Forward Earnings ratio, ACLS is valued a bit cheaper than 71.82% of the companies in the same industry.
ACLS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.43.
Industry RankSector Rank
PE 11.11
Fwd PE 17.25
ACLS Price Earnings VS Forward Price EarningsACLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

94.55% of the companies in the same industry are more expensive than ACLS, based on the Enterprise Value to EBITDA ratio.
86.36% of the companies in the same industry are more expensive than ACLS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.36
EV/EBITDA 5.32
ACLS Per share dataACLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

ACLS has an outstanding profitability rating, which may justify a higher PE ratio.
ACLS's earnings are expected to grow with 24.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2Y-23.26%
EPS Next 3Y24.02%

0

5. Dividend

5.1 Amount

ACLS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (5/20/2025, 8:00:00 PM)

After market: 62.46 0 (0%)

62.46

+0.45 (+0.73%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)07-29 2025-07-29/amc
Inst Owners100.38%
Inst Owner Change1.28%
Ins Owners0.59%
Ins Owner Change2.08%
Market Cap2.01B
Analysts72.86
Price Target85.39 (36.71%)
Short Float %17.64%
Short Ratio7.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)92.39%
Min EPS beat(2)20.83%
Max EPS beat(2)163.95%
EPS beat(4)4
Avg EPS beat(4)49.55%
Min EPS beat(4)2.16%
Max EPS beat(4)163.95%
EPS beat(8)8
Avg EPS beat(8)32.98%
EPS beat(12)12
Avg EPS beat(12)27.59%
EPS beat(16)16
Avg EPS beat(16)26.09%
Revenue beat(2)2
Avg Revenue beat(2)1.57%
Min Revenue beat(2)1.02%
Max Revenue beat(2)2.12%
Revenue beat(4)3
Avg Revenue beat(4)0.56%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)2.12%
Revenue beat(8)7
Avg Revenue beat(8)1.66%
Revenue beat(12)11
Avg Revenue beat(12)1.99%
Revenue beat(16)15
Avg Revenue beat(16)2.52%
PT rev (1m)-9.51%
PT rev (3m)-25.33%
EPS NQ rev (1m)47.47%
EPS NQ rev (3m)47.47%
EPS NY rev (1m)42.15%
EPS NY rev (3m)42.15%
Revenue NQ rev (1m)-2.07%
Revenue NQ rev (3m)-2.07%
Revenue NY rev (1m)-3.78%
Revenue NY rev (3m)-21.68%
Valuation
Industry RankSector Rank
PE 11.11
Fwd PE 17.25
P/S 2.1
P/FCF 16.36
P/OCF 14.52
P/B 1.96
P/tB 1.96
EV/EBITDA 5.32
EPS(TTM)5.62
EY9%
EPS(NY)3.62
Fwd EY5.8%
FCF(TTM)3.82
FCFY6.11%
OCF(TTM)4.3
OCFY6.89%
SpS29.77
BVpS31.92
TBVpS31.92
PEG (NY)N/A
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 13.28%
ROE 17.33%
ROCE 16.09%
ROIC 14.13%
ROICexc 29.12%
ROICexgc 29.12%
OM 19.14%
PM (TTM) 18.58%
GM 44.61%
FCFM 12.82%
ROA(3y)17.39%
ROA(5y)14.66%
ROE(3y)25.25%
ROE(5y)20.89%
ROIC(3y)21.34%
ROIC(5y)18.4%
ROICexc(3y)45.35%
ROICexc(5y)37.49%
ROICexgc(3y)45.35%
ROICexgc(5y)37.49%
ROCE(3y)24.29%
ROCE(5y)20.95%
ROICexcg growth 3Y-3.61%
ROICexcg growth 5Y39%
ROICexc growth 3Y-3.61%
ROICexc growth 5Y39%
OM growth 3Y2.52%
OM growth 5Y24.03%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
F-Score6
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Debt/EBITDA 0.21
Cap/Depr 94.97%
Cap/Sales 1.62%
Interest Coverage 250
Cash Conversion 69.28%
Profit Quality 69.04%
Current Ratio 5.56
Quick Ratio 4.08
Altman-Z 6.34
F-Score6
WACC11.54%
ROIC/WACC1.22
Cap/Depr(3y)109.12%
Cap/Depr(5y)96.53%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.41%
Profit Quality(3y)77.07%
Profit Quality(5y)99.84%
High Growth Momentum
Growth
EPS 1Y (TTM)-25.76%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-33.76%
EPS Next Y-45.21%
EPS Next 2Y-23.26%
EPS Next 3Y24.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.14%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-23.7%
Revenue Next Year-25.43%
Revenue Next 2Y-10.41%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.32%
EBIT growth 3Y18.31%
EBIT growth 5Y54.17%
EBIT Next Year-56.88%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.31%
FCF growth 3Y-3.13%
FCF growth 5YN/A
OCF growth 1Y-38.33%
OCF growth 3Y-2.13%
OCF growth 5YN/A